Related Experiment Videos
PPAR Gamma and Hepatic Stellate Cells.
Saswati Hazra1, Takeo Miyahara, Richard A Rippe
1Department of Pathology, Keck School of Medicine of the University of Southern California, Los Angeles, California 90033', USA. hazra@scf.usc.edu
Comparative Hepatology
|February 13, 2004
Summary
Peroxisome proliferator-activated receptor gamma (PPAR gamma) activation suppresses hepatic stellate cell (HSC) activation markers. PPAR gamma plays a key role in reverting activated HSC to their quiescent state, offering therapeutic potential for fibrogenesis.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Hepatic stellate cell (HSC) activation is central to liver fibrogenesis, involving complex morphological and biochemical alterations.
- This activation process is regulated by the coordinated activity of multiple transcription factors.
Purpose of the Study:
- To investigate the role of Peroxisome proliferator-activated receptor gamma (PPAR gamma) in the regulation of HSC activation.
- To determine the effects of PPAR gamma ligands on markers of HSC activation.
Main Methods:
- Analysis of PPAR gamma activity in activated HSC.
- Assessment of collagen and alpha-smooth muscle actin (alpha-SMA) expression.
- Evaluation of cell proliferation and migration in response to PPAR gamma modulation.
Main Results:
- PPAR gamma activity is diminished in activated HSC.
- PPAR gamma ligands effectively suppress key markers of HSC activation, including collagen and alpha-SMA expression.
- PPAR gamma activation also inhibits HSC proliferation and migration.
Conclusions:
- PPAR gamma is a critical regulator of HSC activation and plays a significant role in the reversion of activated HSC to a quiescent phenotype.
- Modulation of PPAR gamma activity presents a potential therapeutic strategy for liver fibrogenesis.